The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

The massive robot-making, pacemaker-inventing medtech company Medtronic is facing a financial snag: the humble stapler.

Heading into its fourth-quarter 2024 report, Wall Street thought Genuine Parts would earn $1.55 per share, adjusted for ...